(Q40399680)

English

Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs.

scientific article published on 4 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

based on heuristic

inferred from title

author name string

Masaki Nakamura

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Makoto Iwahashi

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Mikihito Nakamori

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kentaro Ueda

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Toshiyasu Ojima

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Teiji Naka

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Koichiro Ishida

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hiroki Yamaue

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

4 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

163-170

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

MHC class II presentation of endogenously expressed antigens by transfected dendritic cells

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Enhanced selective gene expression by adenovirus vector using Cre/loxP regulation system for human carcinoembryonic antigen-producing carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Antitumor effects of interleukin-2 gene-modified fibroblasts in an orthotopic colon cancer model.

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Murine dendritic cells infected with adenovirus vectors show signs of activation

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Persistent, antigen-specific, therapeutic antitumor immunity by dendritic cells genetically modified with an adenoviral vector to express a model tumor antigen

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines

1 reference

https://api.crossref.org/works/10.1159%2F000086770

21 January 2018

Identifiers

10.1159/000086770

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40399680&oldid=1790317942"